1.Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial.
Zhiyi ZHOU ; Ling XU ; Hegen LI ; Jianhui TIAN ; Lijing JIAO ; Shengfu YOU ; Zhifen HAN ; Yi JIANG ; Huiru GUO ; Hui LIU
Journal of Integrative Medicine 2014;12(3):175-81
Traditional Chinese medicine (TCM) is considered an important complementary therapy with beneficial effects for cancer patients. Elderly patients with non-small-cell lung cancer (NSCLC) are a complex patient group with increasing co-morbidity and shrinking physiological reserve, and may derive substantial benefit from the supportive aspects of TCM. Researchers from Shanghai Longhua Hospital found that qi and yin deficiency is a common syndrome in patients with stage III or IV lung cancer. This project was designed to study the combination of single-agent chemotherapy with TCM methods of benefiting qi and yin in elderly patients with advanced NSCLC.
2.Danshen Injection Inhibits Platelets-induced Metastasis of Breast Cancer Cells In Vitro
Huiru TIAN ; Siqin JIANG ; Hong LYU ; Dongliang ZHUO ; Weiran FU ; Jianjiang FU
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(21):79-85
ObjectiveTo observe the effect of Danshen injection (DAN) on platelet (PLT)-induced metastasis of breast cancer cells in vitro. MethodThe 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to observe the effect of DAN on the growth of MDA-MB-231 cells in vitro. Oris™ migration assay was used to determine the effect of DAN (final mass concentrations 4, 8, 16 g·L-1) on PLT (1.5×1010 cells/L)-induced migration of breast cancer cells in vitro. The effect of DAN on PLT-induced cell invasion was detected by Transwell assay. Immunofluorescence and Western blot were used to detect the effect of DAN on the protein expression associated with PLT-induced epithelial-mesenchymal transition (EMT). In addition, enzyme-linked immune-sorbent assay (ELISA) was used to determine the effect of DAN (final mass concentrations 4, 8, 16, 32, 64 g·L-1) on the secretion of transforming growth factor-β1 (TGF-β1). Western blot was used to observe the effect of DAN on the expression of podoplanin (PDPN) protein in MDA-MB-231 cells induced by PLT. ResultCompared with the blank group, the DAN groups (32 and 64 g·L-1) showed decreased A570 (P<0.05, P<0.01), and there was no significant difference in A570 between DAN groups (4, 8, 16 g·L-1). Compared with the blank group, the PLT group showed increased cell migration and invasion, while DAN groups significantly inhibited PLT-induced cell migration and invasion. Compared with the blank group, the PLT group showed decreased expression of E-cadherin, while DAN could significantly reverse this effect of PLT. Compared with the blank group, the PLT group showed increased Slug and Snail protein expression (P<0.05, P<0.01), while DAN significantly reversed Snail protein expression induced by PLT (P<0.05, P<0.01). The content of TGF-β1 in the PLT group increased (P<0.01), while the secretion of TGF-β1 induced by PLT decreased in the DAN groups (16, 32, and 64 g·L-1) (P<0.05, P<0.01), and the secretion of TGF-β1 was not significantly affected in other DAN groups. PDPN protein expression in the PLT group increased (P<0.01), while DAN could significantly inhibit PLT-induced PDPN expression (P<0.01). ConclusionDAN can inhibit PLT-induced migration, invasion, and EMT of breast cancer cells. The mechanism may be related to the direct action between breast cancer cells and tumor cells by down-regulating PDPN expression and interfering with PLT and has nothing to do with the effect of TGF-β1 secretion of PLT.
3.Predictive value of isoform -2 proprostate-specific antigen and its derived indexes for prostate cancer patients with PSA 4-20 ng/mL
Huiru LU ; Liang LIANG ; Hongjun XIE ; Jian HU ; Qian ZHANG ; Zhandong SONG ; Jin HOU ; Ge TIAN ; Xingfa CHEN ; Lei LI
Journal of Modern Urology 2023;28(4):347-350
【Objective】 To evaluate the predictive value of isoform [-2] proprostate-specific antigen, p2 PSA (p2PSA) and its derived indexes for prostate cancer in a Chinese cohort with PSA 4-20 ng/mL. 【Methods】 A total of 139 males scheduled for biopsy were enrolled in the prospective study from Nov.2021 to Jun.2022. The total PSA (tPSA), free PSA (fPSA), fPSA/tPSA (f/t) and p2PSA were collected, and the percentage of p2PSA(%p2PSA) and prostate health index(PHI) were calculated. The predictive value of p2PSA and its derived indexes were compared with traditional indexes with receiver operating characteristic (ROC) curve and Logistic analysis. 【Results】 Prostate cancer was found in 54 cases (38.8%). There were significant statistical differences in tPSA(10.68 vs.8.14, P=0.021), f/t(0.13 vs.0.16, P=0.006), p2PSA(30.25 vs.19.81, P<0.001), %p2PSA(21.52 vs.13.15, P<0.001) and PHI(64.3vs.38.2, P<0.001) between prostate cancer patients and non-prostate cancer patients. The area under the ROC curve (AUC) of tPSA, fPSA, %fPSA, p2PSA, %p2PSA and PHI were 0.63, 0.51, 0.63, 0.71, 0.73, and 0.80, respectively. The inclusion of %p2PSA and PHI significantly increased the prediction efficiency of the basic prediction model (AUC